Skip to main content

. 1984 Oct;37(10):1193–1194. doi: 10.1136/jcp.37.10.1193

Active site directed inhibitor used in the production of antibodies against urokinase.

S A Cederholm-Williams, J M Marshall, H Chissic

PMCID: PMC498967 PMID: 6386894

1193

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Astedt B., Holmberg L., Lecander I., Thorell J. Radioimmunoassay of urokinase for quantification of plasminogen activators released in ovarian tumour cultures. Eur J Cancer. 1981 Feb;17(2):239–244. doi: 10.1016/0014-2964(81)90042-6. [DOI] [PubMed] [Google Scholar]
Cederholm-Williams S. A. Molecular mechanism of fibrinolysis--a system involved with malignant cells. Invasion Metastasis. 1981;1(2):85–98. [PubMed] [Google Scholar]
Coleman P., Kettner C., Shaw E. Inactivation of the plasminogen activator from HeLa cells by peptides of arginine chloromethyl ketone. Biochim Biophys Acta. 1979 Jul 11;569(1):41–51. doi: 10.1016/0005-2744(79)90079-2. [DOI] [PubMed] [Google Scholar]
Ossowski L., Quigley J. P., Reich E. Fibrinolysis associated with oncogenic transformation. Morphological correlates. J Biol Chem. 1974 Jul 10;249(13):4312–4320. [PubMed] [Google Scholar]
Rijken D. C., Wijngaards G., Zaal-de Jong M., Welbergen J. Purification and partial characterization of plasminogen activator from human uterine tissue. Biochim Biophys Acta. 1979 Sep 29;580(1):140–153. doi: 10.1016/0005-2795(79)90205-8. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES